Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

  • I.C. Macdougall
  • , S.D. Roger
  • , A. De Francisco
  • , D.J.A. Goldsmith
  • , H. Schellekens
  • , H.C. Ebbers
  • , W. Jelkmann
  • , G. London
  • , N. Casadevall
  • , W.H. Hörl
  • , D.M. Kemeny
  • , C. Pollock

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)727-732
Number of pages6
JournalKidney International
Volume81
Publication statusPublished - 2012

Cite this